Huayou Group, which participated in the 20 19 medical science and technology exhibition, is the first cancer injection factory with filling production line and automatic loading and unloading freeze crystallization drying production line in China. The research and development achievements of the patent platform "multi-stage drug release technology" were exhibited, and the cooperation opportunities with domestic and foreign committees and R&D committees were sought through innovative pharmaceutical capabilities and high-end production equipment. The development of new pharmaceutical technologies for ADHD and epilepsy drugs mainly focuses on the new drug 505(b)2 and minority generic drugs supervised by the US FDA. Huayou Group has "multi-stage drug release technology", in which "hot melt controlled release technology" has developed a new drug for treating ADHD, and the slow-release drug and the quick-release drug are packed in the same capsule. Another "triple particle controlled release technology" cooperated with American companies to produce a drug for treating epilepsy, which has been listed in China. In June this year 165438+ 10, migraine was obtained as the second indication? Provide patients with more suitable drugs. Anti-cross-contamination and safety improvement of high-end equipment in cancer injection factory